Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LGALS3 | P17931 | 3/20 | 0.58 |
| ▸ | LGALS1 | P09382 | 2/20 | 0.58 |
| ▸ | LGALS9 | O00182 | 1/20 | 0.58 |
| ▸ | LGALS8 | O00214 | 1/20 | 0.58 |
| ▸ | CA12 | O43570 | 3/20 | 0.45 |
| ▸ | CA1 | P00915 | 3/20 | 0.45 |
| ▸ | CA2 | P00918 | 3/20 | 0.45 |
| ▸ | CA9 | Q16790 | 3/20 | 0.45 |
| ▸ | PYGB | P11216 | 6/20 | 0.44 |
| ▸ | GAA | P10253 | 2/20 | 0.44 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.42 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.42 |
| ▸ | TSHR | P16473 | 2/20 | 0.42 |
| ▸ | LMNA | P02545 | 1/20 | 0.42 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| B-D-Galactose SCHEMBL9880688 | 1.00 | LGALS3 (0.58) | LGALS3LGALS1LGALS9LGALS8CA12 | |
| B-D-Galactose SCHEMBL10050866 | 1.00 | LGALS3 (0.58) | LGALS3LGALS1LGALS9LGALS8CA12 | |
| B-D-Galactose SCHEMBL13220216 | 1.00 | LGALS3 (0.58) | LGALS3LGALS1LGALS9LGALS8CA12 | |
| B-D-Galactose SCHEMBL18649521 | 1.00 | LGALS3 (0.58) | LGALS3LGALS1LGALS9LGALS8CA12 | |
| B-D-Galactose SCHEMBL8527882 | 1.00 | LGALS3 (0.58) | LGALS3LGALS1LGALS9LGALS8CA12 | |
| B-D-Galactose SCHEMBL23758905 | 1.00 | LGALS3 (0.58) | LGALS3LGALS1LGALS9LGALS8CA12 | |
| B-D-Galactose SCHEMBL17112445 | 1.00 | LGALS3 (0.58) | LGALS3LGALS1LGALS9LGALS8CA12 | |
| B-D-Galactose SCHEMBL79549 | 1.00 | LGALS3 (0.58) | LGALS3LGALS1LGALS9LGALS8CA12 | |
| B-D-Galactose SCHEMBL21123450 | 1.00 | LGALS3 (0.58) | LGALS3LGALS1LGALS9LGALS8CA12 | |
| B-D-Galactose SCHEMBL9820102 | 1.00 | LGALS3 (0.58) | LGALS3LGALS1LGALS9LGALS8CA12 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 16 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1408118-B1 | ENZYMATIC METHOD OF PRODUCING 4-0-B-D GALACTOPYRANOSYL-D-XYLOSE, 4-0-B-D-GALACTOPYRANOSYL-D-XYLOSE OBTAINED USING SAID METHOD, COMPOSITIONS CONTAINING SAME AND THE USE THEREOF IN EVALUATING INTESTINAL LACTASE | CONSEJO SUPERIOR INVESTIGACION (ES) | 2006-03-29 | — | — | EP | claimed |
| US-5215591-A | Free-flowing, pure and non-hygroscopic beta D-gulcopyranse | BIOSPHERICS INCORPORATED (US) | 1993-06-01 | — | — | US | claimed |
| CN-118184808-A | Kidney bean soluble acidic polysaccharide and preparation method and application thereof | 成都大学 | 2024-06-14 | — | — | CN | disclosed |
| CN-114641577-B | Enzymatic process for the preparation of UDP-galactose | 马克斯·普朗克科学促进学会 | 2023-06-23 | — | — | CN | disclosed |
| EP-2771696-B1 | METHODS MAKING USE OF PANELS OF METABOLITES FOR THE DIAGNOSIS AND DIFFERENTIATION OF NEONATAL ENCEPHALOPATHY | INFANDX AG (DE) | 2022-09-14 | — | — | EP | disclosed |
| CN-114641577-A | Enzymatic process for the preparation of UDP-galactose | 马克斯·普朗克科学促进学会 | 2022-06-17 | — | — | CN | disclosed |
| CN-114630911-A | Enzymatic process for the preparation of UDP-GlcNAc | 马克斯·普朗克科学促进学会 | 2022-06-14 | — | — | CN | disclosed |
| US-10588962-B2 | Carbohydrate-glycolipid conjugate vaccines | MAX-PLANCK-Gesellschaft zur Förderung der Wissenschaften e.V. (DE) | 2020-03-17 | — | — | US | disclosed |
| US-10514383-B2 | Diagnosis and treatment of neonatal encephalopathy | INFANDX AG (DE) | 2019-12-24 | — | — | US | disclosed |
| US-20150238597-A1 | CARBOHYDRATE-GLYCOLIPID CONJUGATE VACCINES | MAX-PLANCK-Gesellschaft zur Förderung der Wissenschaften e.V. (DE) | 2015-08-27 | — | — | US | disclosed |
| US-20140308687-A1 | Method and Use of Metabolites for the Diagnosis and Differentiation of Neonatal Encephalopathy | INFANDX AG (DE) | 2014-10-16 | — | — | US | disclosed |
| US-8017673-B2 | Polymer stabilizer | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2011-09-13 | — | — | US | disclosed |
| US-20100179253-A1 | POLYMER STABILIZER | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2010-07-15 | — | — | US | disclosed |
| EP-2206740-A2 | Polymer stabilizer | Sumitomo Chemical Company, Limited (JP) | 2010-07-14 | — | — | EP | disclosed |
| US-5215591-A | Free-flowing, pure and non-hygroscopic beta D-gulcopyranse | BIOSPHERICS INCORPORATED (US) | 1993-06-01 | — | — | US | disclosed |
| US-5215591-A | Free-flowing, pure and non-hygroscopic beta D-gulcopyranse | BIOSPHERICS INCORPORATED (US) | 1993-06-01 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100179253-A1 | POLYMER STABILIZER | CNOT1, PARP1, FKBP1B | LGALS3 3189/4885LGALS1 1798/4885LGALS9 2863/4885 |
| US-20150238597-A1 | CARBOHYDRATE-GLYCOLIPID CONJUGATE VACCINES | STT3B, STT3A, DDOST | LGALS3 119/4885LGALS1 176/4885LGALS9 153/4885 |
| US-10588962-B2 | Carbohydrate-glycolipid conjugate vaccines | STT3B, STT3A, DDOST | LGALS3 119/4885LGALS1 176/4885LGALS9 153/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.